| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 19, 2026 | Sell(S) | 8K | $83.86 | $679K | 508K |
| Aug 19, 2026 | Sell(S) | 2K | $84.69 | $152K | 506K |
| Aug 19, 2026 | Sell(S) | 100 | $85.65 | $9K | 506K |
| Aug 18, 2026 | Sell(S) | 2K | $81.15 | $154K | 276K |
| Aug 18, 2026 | Sell(S) | 1K | $83.77 | $100K | 243K |
| Aug 18, 2026 | Sell(S) | 17K | $82.21 | $1.4M | 259K |
| Aug 18, 2026 | Sell(S) | 15K | $82.99 | $1.2M | 245K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001470831-26-000848) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for BridgeBio Pharma, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.